NCT06395753
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06395753
Title A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Debiopharm International SA
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | BEL


No variant requirements are available.